Skip to main content

Why the UK's new guidelines on alcohol consumption are misguided

   Dismissing decades of research on alcohol and health, the UK’s new stringent guidelines on drinking bring to mind a quote from champagne lover Sir Winston Churchill: “Statistics are like a lamppost to a drunk; used more for support than illumination.” In announcing the new policy, England’s chief medical officer and neo-prohibitionist Sally Davies scorned the idea that a daily glass of wine could be healthy, proclaiming it an “old wives’ tale” and suggesting a cup of tea instead. The policy is said to be based on the latest statistics, but do these truly shed any new light? We are hardly in the dark about the effects of wine on health, with many thousands of research papers on record.
   Davies’ fundamental mistake is to judge all types of drinking the same while focusing the outcome narrowly on cancer, failing to consider the opposite: that an equally narrow focus on wine drinkers might have different outcomes when overall health is concerned. Nothing in the “latest data” counters the fact that on average, people who drink wine with meals on a daily basis outlive nondrinkers, are healthier, and enjoy a higher quality of life by objective measures. Davies’ advice to avoid any drinking at all several days a week is similarly imprudent as it can only serve to encourage bingeing instead of healthy drinking. All types of drink are not the same, and all types of drinking are also varied in their effect on health.
   The policy shines a spotlight on alcohol and cancer where broad daylight is needed in order to see the whole picture. But even here the statements in the new policy take liberties with the facts, with assertions such as “no level of alcohol consumption is safe” while acknowledging in the same document that drinking within the guidelines carries the same cancer risk as not drinking. But even that self-contradictory statement oversimplifies the question, because the relationship is nonlinear; for wine, many disease conditions including most types of cancer plot out on a J-shaped curve. In other words the risk is lower for moderate drinkers, then about the same, and increasing rapidly with heavy drinking.  Unfortunately for the Brits and their pub culture, the J curve is shallower for beer. Unfortunately for the new policy, it similary fails when alternating drinking and teetotaling.

   Perhaps the UK would do well to heed Churchill’s view on drinking: “I have taken more out of alcohol than alcohol has taken out of me.”

Comments

Popular posts from this blog

Versatile resveratrol: the ultimate skin care ingredient?

  Part 1 Recently I was honored to join Professors David Sinclair of Harvard and Joseph Vercauteren of the University of Montpelleir at an anti-aging symposium at the invitation of Mathilde Thomas of Caudalie in Paris. Caudalie has been using wine extracts (and specifically resveratrol) in their products for more than 15 years, after Vercauteren identified it in wine grape vines. Sinclair has become well known for his work identifying the role of sirtuin (SIRT) genes in anti-aging, and resveratrol as a natural sirtuin activator. While much remains to be proven, it is fair to say that science is finally beginning to have an impact on skin care. With an increasing understanding of what causes aging in skin cells and how botanical antioxidants such as resveratrol work at a molecular level, there is no excuse to use anti-aging skin care products that don’t multitask. Before delving into the potential benefits of resveratrol in skin care, it may help to review ho...

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...